U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.46
    +0.03 (+0.03%)
     
  • Gold

    1,812.90
    +11.40 (+0.63%)
     
  • Silver

    19.85
    +0.19 (+0.96%)
     
  • EUR/USD

    1.0440
    -0.0044 (-0.42%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2088
    -0.0087 (-0.72%)
     
  • USD/JPY

    135.3160
    -0.4120 (-0.30%)
     
  • BTC-USD

    19,503.90
    +273.51 (+1.42%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    25,935.62
    -457.38 (-1.73%)
     

Dow Rallies on News Biden to Pick Yellen as Treasury Secretary

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

By Yasin Ebrahim

Investing.com - The Dow climbed Monday, as positive vaccine news and a WSJ report suggesting President-elect Joe Biden plans to select former Federal Reserve Chair Janet Yellen as Treasury Secretary lifted sentiment.

The Dow Jones Industrial Average rose 1.37%, or 400 points. The S&P 500 was up 0.76%, while the Nasdaq Composite added 0.50%.

Biden will nominate Yellen as Treasury Secretary, the Wall Street Journal reported. During her tenure at the Fed, Yellen was viewed as pro-stimulus, and if nominated is widely expected to support fiscal-boosting measures to shore up the economy.

The news pushed stocks further into the green, following a positive vaccine-fueled rally.

AstraZeneca (NASDAQ:AZN) said its clinical trials showed its Covid-19 vaccine was 70% effective in protecting against the virus. That was below the efficacy rate of rival vaccines from Pfizer (NYSE:PFE), and Moderna (NASDAQ:MRNA). The trial involved two dosing regiments, one of which showed a 90% efficacy rate, and the other with 62%.

In another boost in the fight against the virus, Regeneron's coronavirus antibody cocktail, used by President Trump when he was hospitalized with Covid-19 last month, was granted emergency use authorization by the Food and Drug Administration. Regeneron Pharmaceuticals (NASDAQ:REGN) shares were up nearly 1%.

The backdrop of positive coronavirus treatment-related news prompted investors to up their bets on airlines, banks, and cruise operators – sectors hit hard by the pandemic amid global restrictions to curb the virus.

United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), and American Airlines Group (NASDAQ:AAL) were sharply higher.

Energy, meanwhile, surged nearly 5% on hopes a quicker end to the pandemic could shore up demand. Occidental Petroleum (NYSE:OXY) led the gains in the sector, up 16%.

Tech, meanwhile, turned positive after falling into the red earlier in the day, as gains in chip stocks, led by Micron Technology (NASDAQ:MU), helped offset mixed performance in the Fab 5.

Apple (NASDAQ:AAPL), and Alphabet (NASDAQ:GOOGL) traded lower, while Amazon.com (NASDAQ:AMZN) Facebook (NASDAQ:FB), and Microsoft (NASDAQ:MSFT) traded above the flatline.

In other news, Snap (NYSE:SNAP) jumped 4% after launching a feature on its platform to rival TikTok and Instagram Reels.

On the economic front, the composite Purchasing Managers' Index, which tracks activity in both manufacturing and services together, rose at its fastest pace since March 2015.

Related Articles

Britain's Rolls-Royce raises 2 billion pounds with rights issue

Most Wall Street workers to get lower 2020 bonuses: study

Cano Health to list via $4.4 billion merger with Barry Sternlicht-backed SPAC